Additionally, HIST1H2BK correlates with metastatic CRC cytokine secretion, myeloid leukocyte migration into the tumour, and resistance to proteasome-inhibitor-based anticancer therapy [59]. The gene discussed is H2BC12; the disease is neoplasm.